2021
DOI: 10.1111/lam.13447
|View full text |Cite
|
Sign up to set email alerts
|

Effects of oral sialic acid on gut development, liver function and gut microbiota in mice

Abstract: Sialic acid (N‐acetylneuraminic acid), a 9‐carbon monosaccharide, has been widely studied in immunology, oncology and neurology. However, the effects of sialic acid on organ and intestinal development, liver function and gut microbiota were rarely studied. In this study, we found that oral sialic acid tended to increase the relative weight of liver and decreased the serum aspartate aminotransferase (GPT) activity. In addition, sialic acid treatment markedly reduced gut villus length, depth, the ratio of villus… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
5
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 11 publications
(6 citation statements)
references
References 28 publications
(28 reference statements)
0
5
0
Order By: Relevance
“…50 N-acetylneuraminic acid was also reported to play an important role in regulating liver function, digestive tract development, and GM in mice. 51 In HFD-fed rats, it was capable of attenuating inflammation and oxidative stress. 52 Thus, it could be inferred that upregulation of N-acetylneuraminic acid partly mediated the health promoting efficacy of the HPPCs in mice.…”
Section: ■ Discussionmentioning
confidence: 99%
“…50 N-acetylneuraminic acid was also reported to play an important role in regulating liver function, digestive tract development, and GM in mice. 51 In HFD-fed rats, it was capable of attenuating inflammation and oxidative stress. 52 Thus, it could be inferred that upregulation of N-acetylneuraminic acid partly mediated the health promoting efficacy of the HPPCs in mice.…”
Section: ■ Discussionmentioning
confidence: 99%
“…HMOs could also directly reduce the occurrence of diseases by reducing pathogen infection in infants. The two main mechanisms for HMOs antipathogenic infections are as follows: One is indirect inhibition: the structure of HMOs is the resemblance to the specific receptor of IECs. Thus, they could be used as a soluble pseudoreceptor and directly bind to the surface of viruses, fungi, and bacteria, thereby preventing pathogens from adhering to IECs. , For example, Helicobacter pylori , which causes chronic gastritis, could bind to oligosaccharides containing sialic acid, preventing pathogenic bacteria from adhering to gut cells. , The other is direct inhibition: HMOs bind directly to the receptors of the IECs of the digestive tract. They also block viruses, fungi, bacteria, and other pathogens from adhesion to the IECs receptors through competitive inhibition, thereby preventing the occurrence of infection (Figure ).…”
Section: The Relationship Between Hmos and Gut Microbiotamentioning
confidence: 99%
“…75,76 For example, Helicobacter pylori, which causes chronic gastritis, could bind to oligosaccharides containing sialic acid, preventing pathogenic bacteria from adhering to gut cells. 77,78 The other is direct inhibition: HMOs bind directly to the receptors of the IECs of the digestive tract. They also block viruses, fungi, bacteria, and other pathogens from adhesion to the IECs receptors through competitive inhibition, thereby preventing the occurrence of infection (Figure 3).…”
Section: Microbiotamentioning
confidence: 99%
“…HW10C2, Oblitimonas alkaliphila , Erysipelatoclostridium ramosum , Blautia sp. YL58, Bacteroids thetaiotaomicron , Morganella morganii , and Clostridioides difficile were markedly changed by SA [ 103 ]. SA metabolism plays a major part in the maintaining the microbiota.…”
Section: Broad Impact Of Sa On the Gut Microbiome And Functionmentioning
confidence: 99%